Eric Ng

Eric Ng joined the Post in 1998 after brief stints in a trading company and translation and editing roles at Dow Jones and Edinburgh Financial Publishing. He has close to 20 years of experience covering China's energy, mining and industrial materials sectors, and has recently added biotechnology to his coverage. Eric has a master's of business administration degree.
Eric Ng
Eric Ng joined the Post in 1998 after brief stints in a trading company and translation and editing roles at Dow Jones and Edinburgh Financial Publishing. He has close to 20 years of experience covering China's energy, mining and industrial materials sectors, and has recently added biotechnology to his coverage. Eric has a master's of business administration degree.

Latest from Eric Ng

Gallium: China tightens grip on wonder metal as Huawei works on promising applications beyond 5G

Alexandra Feytis, a consultant at Roskill Information Services, says the US and Europe will keep close watch on China’s dominance of the critical material as new promising applications are developed.

20 Jul 2019 - 4:04AM

Alexandra Feytis, a consultant at Roskill Information Services, says the US and Europe will keep close watch on China’s dominance of the critical material as new promising applications are developed.

Gallium: China tightens grip on wonder metal as Huawei works on promising applications beyond 5G
China’s war chest of rare earth patents give an insight into total domination of the industry

US lobbyists lament lack of governmental effort to cut reliance on Chinese supply of rare earths, warning Beijing could use dominant position to its advantage in trade talks.

20 Jul 2019 - 10:44AM

US lobbyists lament lack of governmental effort to cut reliance on Chinese supply of rare earths, warning Beijing could use dominant position to its advantage in trade talks.

China’s war chest of rare earth patents give an insight into total domination of the industry
From conducting job interviews to vocational training, Swedish start-up sees robots as a game changer

Samer Al Moubayed, CEO and co-founder of Furhat Robotics, which is developing a robotics platform, expects hundreds of uses for robots in the services industry, with each application worth more than a US$1 billion.

18 Jul 2019 - 11:06PM

Samer Al Moubayed, CEO and co-founder of Furhat Robotics, which is developing a robotics platform, expects hundreds of uses for robots in the services industry, with each application worth more than a US$1 billion.

From conducting job interviews to vocational training, Swedish start-up sees robots as a game changer
Furhat Robotics - the Developer of Human-like Service Robots

Samer Al Moubayed, the CEO and co-founder of Furhat Robotics, a Swedish start-up developing robotic applications, says there could be hundreds of uses for human-like service robots, from job interviews to vocational training to customer servicing worth billions of dollars in the next two decades. He envisioned that these robots will become so common that they will be used in schools, offices, hospitals and malls. He recently came to Hong Kong to meet with potential customers, business partners and investors.

18 Jul 2019 - 1:01PM

Samer Al Moubayed, the CEO and co-founder of Furhat Robotics, a Swedish start-up developing robotic applications, says there could be hundreds of uses for human-like service robots, from job interviews to vocational training to customer servicing worth billions of dollars in the next two decades. He envisioned that these robots will become so common that they will be used in schools, offices, hospitals and malls. He recently came to Hong Kong to meet with potential customers, business partners and investors.

Furhat Robotics - the Developer of Human-like Service Robots
How savvy Li Ka-shing profits from this loss-making firm’s ‘healthy ageing’ product

Tru Niagen, a “healthy ageing” supplement, won the investment backing of Li Ka-shing, now in his nineties and, according to ChromaDex founder, a daily user.

16 Jul 2019 - 8:44AM

Tru Niagen, a “healthy ageing” supplement, won the investment backing of Li Ka-shing, now in his nineties and, according to ChromaDex founder, a daily user.

How savvy Li Ka-shing profits from this loss-making firm’s ‘healthy ageing’ product
Bots to dominate financial sector communications within two years in automation wave, messaging firm Symphony says

Symphony Communications Services, a Silicon Valley messaging start-up used by some of the world’s biggest financial-services companies, expects robot-driven traffic on its platform to surpass human-initiated use within two years.

12 Jul 2019 - 8:20AM

Symphony Communications Services, a Silicon Valley messaging start-up used by some of the world’s biggest financial-services companies, expects robot-driven traffic on its platform to surpass human-initiated use within two years.

Bots to dominate financial sector communications within two years in automation wave, messaging firm Symphony says
Beijing should avoid ‘punishing’ Canada over Huawei case, cautions Ottawa’s ex-ambassador to China

Further curbs may bolster rise of new government unfavourable to Beijing, says John McCallum, Canada’s former ambassador to China.

10 Jul 2019 - 11:39AM

Further curbs may bolster rise of new government unfavourable to Beijing, says John McCallum, Canada’s former ambassador to China.

Beijing should avoid ‘punishing’ Canada over Huawei case, cautions Ottawa’s ex-ambassador to China
Rare diseases are not uncommon, and may be the mother lode for the world’s pharmaceutical producers and researchers

Up to 30 million people live with as many as 7,000 types of rare diseases in the United States, the world’s largest and most advanced pharmaceutical market.

6 Jul 2019 - 10:27AM

Up to 30 million people live with as many as 7,000 types of rare diseases in the United States, the world’s largest and most advanced pharmaceutical market.

Rare diseases are not uncommon, and may be the mother lode for the world’s pharmaceutical producers and researchers
A Xi’an girl’s escape from early death sheds light on China’s arduous journey to make drugs affordable for rare diseases

China last year released the first catalogue of rare diseases, covering 121 disorders out of 7,000 known afflictions, allowing overseas clinical trial data to be accepted for approving new drugs for sale.

6 Jul 2019 - 9:58AM

China last year released the first catalogue of rare diseases, covering 121 disorders out of 7,000 known afflictions, allowing overseas clinical trial data to be accepted for approving new drugs for sale.

A Xi’an girl’s escape from early death sheds light on China’s arduous journey to make drugs affordable for rare diseases
Erosion of Hong Kong’s institutional autonomy will hurt advantage over mainland China cities, high credit rating: Moody’s

Potential erosion of Hong Kong’s institutional independence from Beijing over time could diminish the special administrative region’s advantage over mainland Chinese cities, as well as its higher credit rating, Moody’s said on Friday.

6 Jul 2019 - 3:15AM

Potential erosion of Hong Kong’s institutional independence from Beijing over time could diminish the special administrative region’s advantage over mainland Chinese cities, as well as its higher credit rating, Moody’s said on Friday.

Erosion of Hong Kong’s institutional autonomy will hurt advantage over mainland China cities, high credit rating: Moody’s
Hong Kong’s cancer DNA tests industry gets a boost as Taiwanese provider ACT Genomics opens lab

Taiwan-based ACT Genomics opens a HK$20 million laboratory at the Science Park in Sha Tin to process cancer patients’ samples

5 Jul 2019 - 10:53PM

Taiwan-based ACT Genomics opens a HK$20 million laboratory at the Science Park in Sha Tin to process cancer patients’ samples

Hong Kong’s cancer DNA tests industry gets a boost as Taiwanese provider ACT Genomics opens lab
Not enough Hong Kong-listed companies are conducting due diligence before deals, accounting firm Grant Thornton says

Only 41 per cent of business transactions disclosed by Hong Kong-listed companies last year included detailed investigations into the assets and operations being traded, accounting and audit firm Grant Thornton said on Wednesday.

4 Jul 2019 - 9:21PM

Only 41 per cent of business transactions disclosed by Hong Kong-listed companies last year included detailed investigations into the assets and operations being traded, accounting and audit firm Grant Thornton said on Wednesday.

Not enough Hong Kong-listed companies are conducting due diligence before deals, accounting firm Grant Thornton says
Hong Kong electric utility CLP joins the data arms race in an effort to prepare for the ‘future of energy’

Hong Kong electric utility says it is preparing for disruption in the energy sector by investing in a range of smart technologies

28 Jun 2019 - 8:00AM

Hong Kong electric utility says it is preparing for disruption in the energy sector by investing in a range of smart technologies

Hong Kong electric utility CLP joins the data arms race in an effort to prepare for the ‘future of energy’
Foreign start-ups eye China’s vast digital health care market, but finding the right revenue model holds the key to success

Start-ups such as Boston-based Biofourmis have partnered with local health care platforms like Jianke, giving the company access to its vast customer base.

11 Jun 2019 - 11:14AM

Start-ups such as Boston-based Biofourmis have partnered with local health care platforms like Jianke, giving the company access to its vast customer base.

Foreign start-ups eye China’s vast digital health care market, but finding the right revenue model holds the key to success
Shanghai tech board unlikely to challenge Hong Kong’s status as preferred IPO hub for Chinese biotech firms

Investment bankers say the US-China trade war might dampen valuations of biotech companies looking to raise funds in Hong Kong, but their overall numbers are likely to remain intact.

3 Jun 2019 - 8:42AM

Investment bankers say the US-China trade war might dampen valuations of biotech companies looking to raise funds in Hong Kong, but their overall numbers are likely to remain intact.

Shanghai tech board unlikely to challenge Hong Kong’s status as preferred IPO hub for Chinese biotech firms
Chinese tariffs risk US$200 billion of US gas investments, may spoil America’s ambition to become top global exporter

Two-thirds of the 310 million tonnes of planned US LNG annual capacity, spread over 25 projects and requiring more than US$200 billion of investment, have not yet secured financing.

31 May 2019 - 2:12AM

Two-thirds of the 310 million tonnes of planned US LNG annual capacity, spread over 25 projects and requiring more than US$200 billion of investment, have not yet secured financing.

Chinese tariffs risk US$200 billion of US gas investments, may spoil America’s ambition to become top global exporter
China needs it, the US has it, but why might a trade war energy deal not be the easy win it appears to be?

The US will soon be a net exporter of energy, while China is the world’s biggest importer, suggesting it would be an easy part of a trade war deal to achieve.

31 May 2019 - 8:44AM

The US will soon be a net exporter of energy, while China is the world’s biggest importer, suggesting it would be an easy part of a trade war deal to achieve.

China needs it, the US has it, but why might a trade war energy deal not be the easy win it appears to be?
Caught between Trump and its biggest market, America’s sole rare earths mine is an unusual victim in the US-China trade war

The strategy of MP Materials underscores the lopsidedness in one aspect of the complicated US-China commercial relationship, where America had run a trade deficit with China since at least 1985.

27 May 2019 - 9:03AM

The strategy of MP Materials underscores the lopsidedness in one aspect of the complicated US-China commercial relationship, where America had run a trade deficit with China since at least 1985.

Caught between Trump and its biggest market, America’s sole rare earths mine is an unusual victim in the US-China trade war
Explainer: Can the US take back some control of rare earths from China?

China has retaliated against the US’s imposition of up to 25 per cent tariffs on US$200 billion worth of Chinese exports, by slapping duties on US$60 billion worth of US products from June 1, including rare earth products.

26 May 2019 - 8:00PM

China has retaliated against the US’s imposition of up to 25 per cent tariffs on US$200 billion worth of Chinese exports, by slapping duties on US$60 billion worth of US products from June 1, including rare earth products.

Explainer: Can the US take back some control of rare earths from China?
US-China trade war, financial transparency to spur more belt and road projects, says Standard Chartered

China’s commitment to adopt key elements of financial practices used by World Bank and IMF to ensure projects’ debt sustainability will lead to more lending opportunities in countries covered by belt and road, says banker.

20 May 2019 - 7:30AM

China’s commitment to adopt key elements of financial practices used by World Bank and IMF to ensure projects’ debt sustainability will lead to more lending opportunities in countries covered by belt and road, says banker.

US-China trade war, financial transparency to spur more belt and road projects, says Standard Chartered
Li Hejun, once China’s richest man, gets approval from shareholders to take troubled Hanergy unit private

Hanergy Thin Film’s shares were suspended four years ago when they suddenly shed about half their value in an hour

19 May 2019 - 10:30PM

Hanergy Thin Film’s shares were suspended four years ago when they suddenly shed about half their value in an hour

Li Hejun, once China’s richest man, gets approval from shareholders to take troubled  Hanergy unit private
How a Chinese company targeted by US tariffs for the last 10 years has adapted and thrived

Hilong Holding changed its US business model and looked to newer markets after anti-dumping duties were slapped on the Hong Kong-listed provider of oilfield equipment and services.

19 May 2019 - 10:29PM

Hilong Holding changed its US business model and looked to newer markets after anti-dumping duties were slapped on the Hong Kong-listed provider of oilfield equipment and services.

How a Chinese company targeted by US tariffs for the last 10 years has adapted and thrived
More Hong Kong insurers will cover pre-existing illnesses as new voluntary scheme highlights demand, says AXA executive

There’s a huge, unmet demand for health insurance for those with chronic pre-existing conditions in Hong Kong, says Alexander Chiu, a medical director with the insurance giant.

16 May 2019 - 8:41AM

There’s a huge, unmet demand for health insurance for those with chronic pre-existing conditions in Hong Kong, says Alexander Chiu, a medical director with the insurance giant.

More Hong Kong insurers will cover pre-existing illnesses as new voluntary scheme highlights demand, says AXA executive
Investors pile into Viva Biotech’s Hong Kong IPO as they are confident of the R&D services provider’s business model

Not only is the firm profit-making, but its investment in potential drug candidates has made it attractive to investors, says Louis Tse Ming Kwong, managing director of VC Asset Management

13 May 2019 - 9:50PM

Not only is the firm profit-making, but its investment in potential drug candidates has made it attractive to investors, says Louis Tse Ming Kwong, managing director of VC Asset Management

Investors pile into Viva Biotech’s Hong Kong IPO as they are confident of the R&D services provider’s business model
CLP’s plan to buy solar energy from village houses hits a snag

Of the 2,500 applications to sell renewable power to CLP, as many as 13 per cent may face delays or are indefinitely on hold

6 May 2019 - 9:56PM

Of the 2,500 applications to sell renewable power to CLP, as many as 13 per cent may face delays or are indefinitely on hold

CLP’s plan to buy solar energy from village houses hits a snag
Biotech start-up backed by Li Ka-shing and Bill Gates to launch its immunity-boosting gut bacteria in Hong Kong, Singapore

Evolve BioSystems’ dietary supplement works by reintroducing a beneficial gut bacteria that is missing in today’s babies

6 May 2019 - 6:00AM

Evolve BioSystems’ dietary supplement works by reintroducing a beneficial gut bacteria that is missing in today’s babies

Biotech start-up backed by Li Ka-shing and Bill Gates to launch its immunity-boosting gut bacteria in Hong Kong, Singapore
As biotechnology firms become the darlings of Hong Kong’s IPO market, their executives get outsized pay packets. Here’s why

As biotechnology becomes one of the hottest sectors in Hong Kong’s IPO market, biotech executives get extraordinary pay packages, especially in the first year after the companies go to market.

3 May 2019 - 10:31PM

As biotechnology becomes one of the hottest sectors in Hong Kong’s IPO market, biotech executives get extraordinary pay packages, especially in the first year after the companies go to market.

As biotechnology firms become the darlings of Hong Kong’s IPO market, their executives get outsized pay packets. Here’s why
Russia’s plans for Arctic gas may be an alternate source for China’s energy needs, sate Chinese appetite for US energy products

Russia’s agreement with Chinese state-owned oil companies to develop natural gas in the Arctic Circle could provide an alternative source for China’s energy needs

1 May 2019 - 10:04PM

Russia’s agreement with Chinese state-owned oil companies to develop natural gas in the Arctic Circle could provide an alternative source for China’s energy needs

Russia’s plans for Arctic gas may be an alternate source for China’s energy needs, sate Chinese appetite for US energy products
Hong Kong pharma start-up joins with Singapore technology agency in venture fund

Aptorum Group plans to invest alongside A*ccelerate Technologies in promising Singaporean health-care start-ups

28 Apr 2019 - 9:53PM

Aptorum Group plans to invest alongside A*ccelerate Technologies in promising Singaporean health-care start-ups

Hong Kong pharma start-up joins with Singapore technology agency in venture fund
Temasek unit-backed firm Lucence to tap Hong Kong cancer screening market

Lucence Diagnostics, a Singapore-based cancer screening and DNA testing company, is considering setting up a laboratory in Hong Kong to better compete in the liquid biopsy market.

26 Apr 2019 - 7:00AM

Lucence Diagnostics, a Singapore-based cancer screening and DNA testing company, is considering setting up a laboratory in Hong Kong to better compete in the liquid biopsy market.

Temasek unit-backed firm Lucence to tap Hong Kong cancer screening market